qual-quan mass spec
Alzheimer's Disease Proteomic Study Reveals Potential New Biomarkers, Drug Targets
Brain samples from Alzheimer's cases and controls revealed an energy metabolism-related protein network with ties to microglia and astrocyte activity.
With executives from Agilent, Thermo Fisher, Waters, and Danaher presenting this week at the JP Morgan Healthcare Conference, UPLC as well as triple quadrupole and qual-quan mass spec proved primary areas of discussion.
The release of a long-awaited protein biomarker test, increased adoption of a major instrument platform, and a pair of proteome mapping milestones marked a year in which several much-anticipated advances in proteomics arrived.